Lester Andrew Uy

Dr. Lester Andrew Uy

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2025 in The American Surgeon™
Verified
Journal Article
Closed access
STSeth Tivakaran
Seth Tivakaran
JRJulia L. Raghu
Julia L. Raghu
JLJeff C. K. Leung
Jeff C. K. Leung
KTKing Sum Tong
King Sum Tong
NPNicholas L. Panyanouvong
Nicholas L. Panyanouvong
JVJeffrey B. Velotta
Jeffrey B. Velotta
Background: Lung cancer is the leading cause of cancer-related deaths worldwide in Asian Americans (AsA), yet AsA lung cancer screening (LCS) rates are unknown. We examined LCS rates in AsA within Kaiser Permanente Northern California (KPNC), a large integrated healthcare system where LCS is a member benefit. The California LCS rate is 0.7%. Methods: This cohort study analyzed KPNC 2015-2022 electronic health records. Lung cancer screening rates were compared among AsA subgroups, controlling for sociodemographics, considering both more restrictive 2013 (n = 2,273) and more inclusive 2021 (n = 5,823) United States Preventive Services Task Force (USPSTF) LCS guidelines, which differ by age range and years post-smoking cessation. Results: Overall KPNC LCS rates for eligible AsA patients were 4.3% and 2.7% using USPSTF 2013 and 2021 guidelines, respectively. Lung cancer screening rates varied by AsA subgroup. Under 2021 guidelines, Chinese (4.0%) were screened more than Korean (3.57%), Southeast Asian (3.52%), Japanese (3.19%), Asian (Other) (2.28%), Pacific Islander (1.91%), and Filipino (1.55%). Under 2013 guidelines, Southeast Asian (6.54%) were screened more than Chinese (6.51%), Japanese (5.36%), Asian (Other) (3.95%), and Filipino (1.93%). Discussion: This is the first study to demonstrate significant heterogeneity in LCS rates for disaggregated AsA subgroups. Kaiser Permanente Northern California LCS rates were 4× California rates. When payment alone is not a care barrier, systemic and culturally sensitive interventions are necessary to increase overall LCS screening rates and address population-specific disparities.

6 June 2026 in Cancers
Verified
Journal Article
Open access
PDF file
BKBani Kaur
Bani Kaur
ABAvinav Biswas
Avinav Biswas
TCTyler Christian Chervo
Tyler Christian Chervo
WAWoo Jin Ahn
Woo Jin Ahn
SGShangzi Gao
Shangzi Gao
JVJeffrey Velotta
Jeffrey Velotta
Background: Despite a decline in lung cancer in the U.S., lung cancer among never-smoking Asian American (AsA) women is rising, and subgroup aggregation obscures heterogeneity. We compared primary lung cancer prevalence across disaggregated AsA subgroups and examined factors associated with prevalence such as personal- and family-cancer histories versus Non-Hispanic Whites (NHWs). Methods: This cross-sectional study analyzed electronic health records of AsA women (≥18) in a large Northern California health system (2010–2022). Lung cancer cases were obtained from the hospital registry and categorized by smoking status and self-reported ethnicity. Adjusted prevalence ratios (aPRs) were estimated using targeted maximum likelihood estimation, accounting for sociodemographic, smoking, and clinical covariates. Results: Among 1,843,119 women, 8651 had primary lung cancer; 2429 were never-smokers. In AsA never-smokers, aPRs and 95% confidence intervals versus age-matched NHW were: Chinese (3.36, [3.20–3.53]), Filipino (2.68, [2.55–2.82]), Vietnamese (2.07, [1.96–2.18]), Japanese (1.99, [1.89–2.10]), Korean (1.90, [1.80–2.00]), and Other Asian (0.35, [0.33–0.37]). Personal cancer-history reflected an increase in prevalence among Korean patients (2.91, [2.76–3.06]) while family cancer-history demonstrated increased prevalence among Chinese patients (1.51, [1.42–1.60]). Among women with uterine cancer, Chinese patients had higher lung-cancer prevalence than NHW (1.91, [1.58–2.31]). Conclusions: Never-smoking disaggregated AsA women show heterogeneous lung cancer prevalence, with higher prevalence in Korean women with personal cancer-history and in Chinese women with family cancer-history compared with NHW, supporting history-informed and ethnic-specific lung cancer screenings.

1 May 2026 in The Lancet Regional Health - Americas
Verified
Journal Article
Open access
LULester Andrew Uy
Lester Andrew Uy
ECEllen Chang
Ellen Chang
SDSanya Desai
Sanya Desai
MRMiguel Esteban Villarreal Rodriguez
Miguel Esteban Villarreal Rodriguez
GHGeorge A. Hung
George A. Hung
SSSteven Sust
Steven Sust
Among U.S. youth aged 15–24 years, suicide is the leading cause of death for Asian American youth, yet surveillance data are rarely disaggregated by racial subgroup. We examined whether suicide mortality differs across six Asian American subgroups. We analyzed National Center for Health Statistics mortality data for 2005 through 2022, linked with American Community Survey population denominators. Deaths from intentional self-harm (ICD-10 codes X60–X84, Y87.0) were identified among Asian Indian, Chinese, Filipino, Japanese, Korean, and Vietnamese youth, with non-Hispanic White and Asian Youth as comparison groups. We calculated annualized mortality rates (AMR), rate ratios (RR), proportional mortality, proportional mortality ratios, crude mortality rate (CMR) trends, and annual percentage changes (APC) using Joinpoint regression with heteroscedastic error models. Between 2005 and 2022, 2519 Asian American youth died by intentional self-harm. The AMR for Asian Youth was 8.37 per 100,000 (95% CI, 8.04–8.69), compared with 14.34 (14.23–14.46) for non-Hispanic White youth. Korean youth had the highest AMR (9.92; 8.87–10.97) and mortality (33.8%; 30.9–36.7); Chinese youth had the lowest AMR (6.38; 5.87–6.90). Among Asian Youth, Korean (RR, 1.19; 1.06–1.33), Vietnamese (1.14; 1.03–1.27), and Filipino (1.13; 1.03–1.24) youth had significantly elevated mortality. Four subgroups showed sustained CMR increases (APC, 4.9–9.1%), while Asian Indian youth rose significantly before declining. These trends contrast with a post-2018 decline among non-Hispanic White youth. State-level analysis demonstrated substantial inter-subgroup heterogeneity. Disaggregation reveals clinically meaningful variation in mortality that aggregated surveillance conceals. Race-specific, culturally grounded prevention strategies are needed, particularly for Korean, Vietnamese, and Filipino youth who bear a disproportionate and growing burden. This study received no external funding. The Stanford Center for Asian Health Research and Education provided institutional support; the Chi-Li Pao Foundation USA supported conference dissemination.

26 May 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
BKBani Kaur
Bani Kaur
ABAvinav Biswas
Avinav Biswas
TCTyler Christian Chervo
Tyler Christian Chervo
WAWoo Jin Ahn
Woo Jin Ahn
SGShangzi Gao
Shangzi Gao
JVJeffrey Velotta
Jeffrey Velotta
Background: Despite decline in lung cancer in the U.S., lung cancer among never-smoking Asian American (AsA) women is rising, and subgroup aggregation obscures heterogeneity. We compared primary lung cancer prevalence across disaggregated AsA subgroups and examined associations with risk factors such as personal- and family-cancer histories versus non-Hispanic Whites (NHW). Methods: This cross-sectional study analyzed electronic health records of AsA women (≥18) in a large Northern California health system (2010–2022). Lung cancer cases were obtained from the hospital registry and categorized by smoking status and self-reported ethnicity. Adjusted prevalence ratios (aPRs) were estimated using targeted maximum likelihood estimation, accounting for sociodemographic, smoking, and clinical covariates. Results: Among 1,843,119 AsA women, 8,651 had primary lung cancer; 2,429 were never-smokers. In never-smokers, aPRs and 95% confidence intervals versus age-matched NHW were: Chinese (3.36, [3.20–3.53]), Filipino (2.68, [2.55–2.82]), Vietnamese (2.07, [1.96–2.18]), Japanese (1.99, [1.89–2.10]), Korean (1.90, [1.80–2.00]); Other Asian (0.35, [0.33–0.37]). Personal cancer-history reflected an increase in prevalence among Korean patients (2.91, [2.76–3.06]) while family cancer-history demonstrated increased prevalence among Chinese patients (1.51, [1.42–1.60]). Among women with uterine cancer, Chinese patients had higher lung-cancer prevalence than NHW (1.91, [1.58–2.31]). Conclusions: Never-smoking disaggregated AsA women show heterogeneous lung cancer prevalence, with higher prevalence in Korean women with personal cancer-history and in Chinese women with family cancer-history compared with NHW, supporting history-informed and ethnic-specific lung cancer screenings.